Literature DB >> 9215276

Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation.

J Argente1, N Caballo, V Barrios, M T Muñoz, J Pozo, J A Chowen, G Morandé, M Hernández.   

Abstract

We have studied the GH-insulin-like growth factor (IGF) axis in patients with anorexia nervosa at the time of diagnosis and at two points during weight recuperation. We report their spontaneous GH secretion and IGF-I, free IGF-I (fIGF-I), IGF-II, the IGF-binding proteins (IGFBP-1, IGFBP-2, and IGFBP-3), and GH-binding protein (GHBP) levels at the time of the clinical diagnosis (n = 50) and after recuperation of between 6-8% (n = 42) and 10% or less of the initial weight (n = 20). Two distinct groups were seen, those who significantly hypersecreted GH and those whose GH secretion was reduced significantly. After recuperation of 10% or more of their initial weight, all patients had a normal GH pattern. Independently of GH secretory dynamics, IGF-1, IGFBP-3, and GHBP serum levels were all significantly decreased at diagnosis, and only GHBP returned to normal after weight recuperation. Serum IGFBP-1 and IGFBP-2 levels were significantly increased at the time of diagnosis and decreased after weight recuperation. The body mass index (BMI) correlated positively with fIGF-I levels and negatively with IGFBP-1 and IGFBP-2 levels, but only after weight recuperation in all cases. Contrary to what is seen in normal individuals, no correlation was found between BMI and serum GHBP levels in anorexia nervosa patients. Serum IGFBP-2 levels had a strong negative correlation with fIGF-I, IGF-II, and the sum of IGF-I and IGF-II, but only at the time of diagnosis. In conclusion, the GH-IGF axis is dramatically altered in patients with anorexia nervosa. Changes in the peripheral IGF system however, appear to be independent of modifications in GH secretion and, in contrast to current thought, not all of the observed abnormalities are rapidly reversed with weight recuperation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215276     DOI: 10.1210/jcem.82.7.4090

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

1.  Development of acromegaly in a patient with anorexia nervosa: pathogenetic and diagnostic implications.

Authors:  E de Menis; M Gola; A Giustina
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

Review 2.  The endocrine manifestations of anorexia nervosa: mechanisms and management.

Authors:  Melanie Schorr; Karen K Miller
Journal:  Nat Rev Endocrinol       Date:  2016-11-04       Impact factor: 43.330

3.  Determinants of skeletal loss and recovery in anorexia nervosa.

Authors:  Karen K Miller; Ellen E Lee; Elizabeth A Lawson; Madhusmita Misra; Jennifer Minihan; Steven K Grinspoon; Suzanne Gleysteen; Diane Mickley; David Herzog; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2006-05-30       Impact factor: 5.958

4.  Improvement in growth after 1 year of growth hormone therapy in well-nourished infants with growth retardation secondary to chronic renal failure: results of a multicenter, controlled, randomized, open clinical trial.

Authors:  Fernando Santos; M Llanos Moreno; Arlete Neto; Gema Ariceta; Julia Vara; Angel Alonso; Alberto Bueno; Alberto Caldas Afonso; António Jorge Correia; Rafael Muley; Vicente Barrios; Carlos Gómez; Jesús Argente
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-03       Impact factor: 8.237

Review 5.  Endocrine consequences of anorexia nervosa.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-02       Impact factor: 32.069

Review 6.  Potential applications for rhIGF-I: Bone disease and IGFI.

Authors:  Marisol Bahamonde; Madhusmita Misra
Journal:  Growth Horm IGF Res       Date:  2020-03-23       Impact factor: 2.372

Review 7.  Bone metabolism in anorexia nervosa: molecular pathways and current treatment modalities.

Authors:  D J Howgate; S M Graham; A Leonidou; N Korres; E Tsiridis; E Tsapakis
Journal:  Osteoporos Int       Date:  2012-08-09       Impact factor: 4.507

8.  The adrenal sensitivity to ACTH stimulation is preserved in anorexia nervosa.

Authors:  F Lanfranco; L Gianotti; A Picu; S Fassino; G Abbate Daga; V Mondelli; R Giordano; S Grottoli; E Ghigo; E Arvat
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

9.  The effect of caloric restriction interventions on growth hormone secretion in nonobese men and women.

Authors:  Leanne M Redman; Johannes D Veldhuis; Jennifer Rood; Steven R Smith; Donald Williamson; Eric Ravussin
Journal:  Aging Cell       Date:  2009-10-30       Impact factor: 9.304

10.  Leptin does not mediate short-term fasting-induced changes in growth hormone pulsatility but increases IGF-I in leptin deficiency states.

Authors:  Jean L Chan; Catherine J Williams; Patricia Raciti; Jennifer Blakeman; Theodore Kelesidis; Iosif Kelesidis; Michael L Johnson; Michael O Thorner; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.